The treatment of some cancers has shifted from conventional chemotherapy drugs to chronic treatment with molecular targeted therapies. Targeted therapies include drugs such as Tyrosine kinase inhibitors (eg: Imatinib, Dasatinib, Nilotinib, Sunitinib,
Sorafenib, Vandetanib, Lapatinib, Vatalanib and Erlotinib) that present better efficiency and lower side effects than conventional anti cancer drugs.
United States
